Teva Gets Investment From Royalty On Olanzapine LAI

Follows Successful Launch Of Uzedy LAI Risperidone In The US Earlier This Year

 
• By David Wallace
  
Dollar sign wearing crown with gold background
Teva has garnered investment from Royalty in olanzapine LAI • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business